Who is sponsoring NCT03453580?

NCT03453580 is sponsored by Assiut University.

What drugs are being tested in NCT03453580?

Interventions in NCT03453580: multislice computed tomography portography.

What condition does NCT03453580 study?

NCT03453580 studies CT Portography Grading of Liver Cirrhosis.

Is NCT03453580 still recruiting?

NCT03453580 is currently status unknown. Last updated 27 June 2018.

Last reviewed 2018-06-27 · How we verify

NCT03453580

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CT Portography in Grading of Liver Cirrhosis

Status unknown Last updated 27 June 2018

What this trial tests

trial testing multislice computed tomography portography in CT Portography Grading of Liver Cirrhosis in 100 participants. Status unknown.

Timeline

25 September 2018

Primary endpoint
30 September 2019

30 October 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	25 September 2018
Primary completion	30 September 2019
Estimated completion	30 October 2019

Drugs / interventions tested

multislice computed tomography portography

Conditions studied

CT Portography Grading of Liver Cirrhosis — all drugs for CT Portography Grading of Liver Cirrhosis →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with CT Portography Grading of Liver Cirrhosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Esophageal variceal bleeding and hepatic encephalopathy are serious complications of hepatic cirrhosis, and they may lead to high mortality rate and severely threaten life quality of the patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03453580 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 27 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03453580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing